Matthew K Fust's Net Worth

Matthew K Fust's net worth is estimated to be at least $8,831,438.22 as of 05/27/2024. CoreStreet's estimation of Matthew K Fust's net worth is based on their sale of stock and current holding of stock.

Matthew K Fust is Director at Crinetics Pharmaceuticals Inc. They have executed at least 22 trades of stock as per SEC Form 4 filings. Their most recent trade was for 60,000 units of CRNX stock on 03/20/2024. Their biggest sale was on 03/20/2024 when they sold 60,000 units of Crinetics Pharmaceuticals Inc stock for $2,648,400.00. They typically trade 2 times per year.

Total value of insider buys:
  • $100,620.00
Total value of insider sells:
  • $8,730,818.22
Most recent insider trade:
  • March 20, 2024

Matthew K Fust's Insider Trading History

Crinetics Pharmaceuticals IncTitleAmountPriceTypeTotal Value
March 20, 2024
Director60,000$44.14Sell$2,648,400.00
July 13, 2022
Director5,700$20.96Sell$119,472.00
Nov. 1, 2021
Director8,954$25.50Sell$228,327.00
Sept. 8, 2021
Director6,046$25.50Sell$154,173.00
July 26, 2021
Director5,000$19.59Sell$97,950.00
July 19, 2021
Director5,000$19.50Sell$97,500.00
July 12, 2021
Director5,000$20.71Sell$103,550.00
Dec. 16, 2019
Director3,500$22.50Sell$78,750.00
UltragenyxTitleAmountPriceTypeTotal Value
March 7, 2024
Director12,195$50.88Sell$620,481.60
July 6, 2020
Director6,181$90.00Sell$556,290.00
July 1, 2020
Director5,000$85.00Sell$425,000.00
May 30, 2018
Director6,319$72.00Sell$454,968.00
Atara Biotherapeutics IncTitleAmountPriceTypeTotal Value
Nov. 4, 2021
Director13,354$19.50Sell$260,403.00
May 14, 2018
Director12,286$43.57Sell$535,301.02
Journey Medical Corporation Common StockTitleAmountPriceTypeTotal Value
Dec. 12, 2019
Director3,000$12.00Sell$36,000.00
Sept. 12, 2019
Director6,000$8.77Sell$52,620.00
Oct. 19, 2018
Director4,000$13.75Sell$55,000.00
Nov. 25, 2014
Director6,000$16.77Buy$100,620.00
MacroGenics IncTitleAmountPriceTypeTotal Value
Feb. 6, 2019
Director6,924$29.38Sell$203,427.12
Amgen IncTitleAmountPriceTypeTotal Value
July 26, 2013
CFO6,043$130.50Sell$788,611.50
July 2, 2013
CFO1,551$132.80Sell$205,972.80
May 13, 2013
CFO10,269$98.22Sell$1,008,621.18